Clinical Trial Update: The Efficacy and Safety Study of Dabigatran and Warfarin to Non-valvular Atrial Fibrillation Patients [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update examining the efficacy and safety of dabigatran compared with warfarin in patients with non-valvular atrial fibrillation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-valvular Atrial Fibrillation

Drugs mentioned

• Dabigatran (Dabigatran etexilate)
• Warfarin (warfarin)

Snippet

Sponsor: The First Affiliated Hospital with Nanjing Medical University | Conditions: Atrial Fibrillation | Phase 4 | Status: UNKNOWN